Evidence map›Paper›PMID 42540151›Full record

ArticleTetrahedron2018

Rapid Solid-phase Syntheses of Peptidic-Aminoglycoside Library.

Casey Kukielski, Krishnagopal Maiti, Sayantan Bhaduri, Sandra Story, Dev P Arya

Abstract read
In one paragraph

Article in Tetrahedron, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Casey KukielskiLaboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.
Krishnagopal MaitiLaboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.
Sayantan BhaduriNUBAD, LLC, Greenville, South Carolina 29605, United States.
Sandra StoryNUBAD, LLC, Greenville, South Carolina 29605, United States.
Dev P AryaLaboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.

Funding

Development of peptide nucleic acid antibiotics-supplement 1R42AI114114 · NIAID · NUBAD, LLC · PI ARYA, DEV PRIYA · 2021 to 2024
$3.2M
A Rapid assay for RNA targeted drugs: Instrumentation SupplementR42GM097917 · NIGMS · NUBAD, LLC · PI ARYA, DEV PRIYA · 2014 to 2015
$1.4M
Development of Peptide Antibiotic Nucleic AcidsR41AI114114 · NIAID · NUBAD, LLC · PI ARYA, DEV PRIYA · 2014 to 2015
$595k
A novel assay for RNA targeted drugsR41GM097917 · NIGMS · NUBAD, LLC · PI ARYA, DEV PRIYA · 2011 to 2011
$286k
NIAID NIH HHS R41 AI114114NIAID NIH HHS R42 AI114114NIGMS NIH HHS R41 GM097917NIGMS NIH HHS R42 GM097917
6 · The paper itself

Abstract

A library of mono- and di-amino acid peptidic-aminoglycosides (PAs), with kanamycin and neomycin as the model aminoglycosides, was systematically and rapidly synthesized via solid phase peptide synthesis. Aminoglycosides were first converted into

Identifiers

PMID42540151
PMCPMC13425277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.